Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

Seventy-eight-year-old Joe Walsh, of Quincy, is in a unique position. He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate ...

As a community pharmacist in Nova Scotia, I have witnessed the ongoing effects of the opioid crisis firsthand. This public ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.